Company: NKLR
Filing Date: 2025-12-09
Form Type: S-1/A
Source: 0001213900-25-119411
Chunk: 111

Company: Terra Innovatum Global N.V.
Filing Date: 2025-12-09
Form: S-1/A
Chunk 111
---
 guidance of ASC 815. Therefore, the freestanding equity-linked instrument has been recorded as a liability at its estimated fair value, with the offsetting amount recorded to additional paid-in capital. The value of the Share-settled contingent liability was calculated using a probability weighted-average analysis of the achievement of each of the milestones and a Monte Carlo simulation model. The simulation incorporated (i) an underlying share price of $7.41 per share, (ii) a 3.9% risk free rate, and (iii) an estimated volatility of 125% based on historical data of comparable public companies.

| (c) | To reflect the issuance of 223,000 PubCo Ordinary Shares to PAC                                     
 upon the Closing for banking advisory services provided to Terra Innovatum. The issuance            
 of the shares was accounted for in accordance with Staff Accounting Bulletin Topic 5.A (“SAB        
 Topic 5.A”) as a specific incremental cost associated with the equity offering, with                
 the grant date fair value recorded as a decrease to additional paid-in capital with a corresponding 
 increase to par value.                                                                              |

| (d) | To reflect the                                                              
 settlement of GSR III’s deferred underwriting fee payable upon the Closing. |

| (e) | To reflect the payment on the Closing Date of total transaction 
 costs of $2.7 million related to GSR III, including:            |

(i) $167.3 thousand of costs incurred after September 30, 2025, which are not specific incremental costs directly attributable to the offering. (ii) $2.5 million of costs incurred prior to September 30, 2025, which are not specific incremental costs directly attributable to the offering. 72 In accordance with Staff Accounting Bulletin Topic 5.A and ASC 340-10-S99-1, management evaluated the nature of all transaction-related costs. Based on this evaluation:

| o | $167.3                                                                                        
 thousand of costs incurred after September 30, 2025 were expensed as incurred and recorded    
 as an addition to accumulated deficit in the pro forma balance sheet. These costs primarily   
 include accounting and audit services for historical financial statements and other financial 
 services. None of these services were specific incremental costs directly attributable to     
 the offering.                                                                                 |
| o | $2.5 million of costs incurred prior to September                                             
 30, 2025 were expensed as incurred and recorded as an addition to accumulated deficit in      
 the pro forma balance sheet. These costs primarily include legal